New fertility study by Shady Grove Fertility (SGF) provides hope for those diagnosed with cancer
ROCKVILLE, Md., Oct. 25, 2022 /PRNewswire-PRWeb/ -- New research from Shady Grove Fertility (SGF), conducted with the University of Colorado School of Medicine and the School of Public Health, has shown that patients with a recent cancer diagnosis can expect comparable results from fertility preservation treatment to those who are undergoing elective egg-freezing.
- Shady Grove Fertility's research team presented an award-winning study at ASRM 2022 that can provide reassurance for patients undergoing fertility preservation treatment following a cancer diagnosis.
- Presented this week at the 78th ASRM Scientific Congress & Expo in Anaheim, California, the study was selected as the Fertility Preservation Special Interest Group Prize Paper.
- This new information can provide additional reassurance for patients with cancer who are planning to have biological children in the future.
- SGF is among the founding partner practices of US Fertility , the largest physician-led partnership of top-tier fertility practices in the U.S.